Frontier IP Group plc Royal Society of Chemistry Nominations

TIDMFIPP

Frontier IP Group plc

09 May 2017

RNS REACH

AIM: FIPP

9 May 2017

Frontier IP Group Plc

("Frontier IP" or the "Group")

Three Group nominations for Royal Society of Chemistry awards

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that two of its portfolio companies, Alusid Limited ("Alusid") and Exscientia Limited ("Exscientia") have received nominations for a total of three awards at the Royal Society of Chemistry's forthcoming Chemistry World flagship event in June.

Alusid has been shortlisted for the Emerging Technologies competition for its multi-award winning Architectural surfacing Eco-materials, made from fused recycled glass and ceramics using a low energy process, designed as an adaptable alternative to natural stone. Alusid aims to be a leader in the supply of premium engineered sustainable architectural materials and remains at the forefront of this growing sector through continuous research and development.

Exscientia is at the forefront of small molecule drug discovery. It applies a wealth of AI techniques to automate drug design in a manner that surpasses conventional human endeavour. In just three years Exscientia has already grown a portfolio of global collaborations that include Sanofi, Sumitomo Dainippon and Sunovion. Exscientia sees two of its staff shortlisted to the final three, Andrew Hopkins, as Chemistry World Entrepreneur of the Year and Jérémy Besnard for the Rising Star in Industry Award.

Neil Crabb, CEO of Frontier IP, commented "It is pleasing to see both companies continuing to garner recognition for the excellence of their technologies and people as they drive commercial success in their respective marketplaces".

ENDS

For further information:

 
 Frontier IP Group Plc                    T: 0131 240 1251 
 Neil Crabb, Chief Executive 
  Company website: www.frontierip.co.uk 
 
 Cenkos Securities plc (Nominated         T: 0131 220 6939 
  Adviser and Joint Broker) 
 Neil McDonald / Beth McKiernan 
 
 Peterhouse Corporate Finance             T: 020 7469 0935 
  Limited (Joint Broker) 
 Lucy Williams 
 
 Kreab (Financial PR)                     T: 020 7074 1800 
 Robert Speed / Matthew Jervois 
 

Notes to Editor:

About Frontier IP Group plc

www.frontierip.co.uk.

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses.

About Alusid

www.alusid.co.uk

ALUSID - a university spinoff company - was born from a research project led by Professor David Binns and Dr Alasdair Bremner, at the University of Central Lancashire. Alusid aims to be a leader in the supply of premium engineered sustainable architectural materials and remains at the forefront of this growing sector through continuous research and development.

About Exscientia

www.exscientia.co.uk

Exscientia is at the forefront of Artificial Intelligence (AI)-driven drug discovery and design. By fusing the power of AI with the discovery experience of seasoned drug hunters, it is the first company to automate drug design, surpassing conventional approaches. Its innovative platform enables breakthrough productivity gains with new approaches to improve drug efficacy. It is delivering a pipeline of efficacious, bispecific small molecules, as well as highly selective single target candidates, for multiple indications.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAFKLFBDEFBBBX

(END) Dow Jones Newswires

May 09, 2017 07:05 ET (11:05 GMT)